Crisis over shortage of Remdesivir, Fabiflu to end by next fortnight

"An unprecedented surge in demand of some crucial medicines, used in treating Covid patients, has created a mess. Now companies like Cipla or Cadila, and others have increased production of vials manifolds. We promise supplies will be sufficient, "Rajiv Singhal, General Secretary of All India Organisation of Chemists and Druggists(AIOCD), representing over 9.50 lakh chemists across the country, told IANS.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2PDfjT8
via IFTTT